EUVIMEDEUVIMED entdecken
Crossref

Indomethacin Treatment in Patent Ductus arteriosus

Richard M. Nestrud, Donald E. Hill, Robert W. Arrington, Alice G. Beard, William T. Dungan, Pui-Yan Lau, J.B. Norton, Richard I. Readinger

Developmental Pharmacology and Therapeutics · 2019

DOI: 10.1159/000455530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Pharmacology and Therapeutics, 2019. Verfasst von Richard M. Nestrud und 7 weiteren Autor:innen. Die Arbeit wurde bisher 33-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

23 premature infants were placed on a randomized double-blind study to evaluate the effectiveness of indomethacin in closing a patent ductus arteriosus. Infants received 0. 2 mg/kg indomethacin or placebo by gavage. In the trea tment group, 7 patients responded out of a total of 12, while in the placebo group, 2 responded out of a total of 11. lndomethacin plasma levels were obtained in 6 patients in the treatment group. Plasma levels showed markcd variability in peak level (60-3,100 ng/ml), time to peak level (0.5-6 h) and t1/2 (1 to > 24 h).

Zitieren

APA

Nestrud, R. M., Hill, D. E., Arrington, R. W., Beard, A. G., Dungan, W. T., Lau, P., Norton, J., & Readinger, R. I. (2019). Indomethacin Treatment in Patent Ductus arteriosus. Developmental Pharmacology and Therapeutics. https://doi.org/10.1159/000455530

Vancouver

Nestrud RM, Hill DE, Arrington RW, Beard AG, Dungan WT, Lau P, et al. Indomethacin Treatment in Patent Ductus arteriosus. Developmental Pharmacology and Therapeutics. 2019. doi:10.1159/000455530

BibTeX
@article{Nestrud2019,
  author = {Nestrud, Richard M. and Hill, Donald E. and Arrington, Robert W. and Beard, Alice G. and Dungan, William T. and Lau, Pui-Yan and Norton, J.B. and Readinger, Richard I.},
  title = {Indomethacin Treatment in Patent Ductus arteriosus},
  journal = {Developmental Pharmacology and Therapeutics},
  year = {2019},
  doi = {10.1159/000455530}
}
Kostenlos starten →